Language selection

Search

2018-04-10 - Unknown

901834342

Adverse reaction report number 901834342
Latest AER version number 0
Market authorization holder AER number CA201803969
Initial received date 2018-04-10
Latest received date 2018-04-10
Age N/A
Gender Unknown
Weight N/A
Type of report Spontaneous
Reporter type Other Health Professional
Source of report MAH
Report outcome Death
Serious report? Yes

Reason for seriousness

Death Yes
Disability
Cogenital anomaly
Life threateting
Hospitalization
Other medically important Yes

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral0.091 Milligram0 Disturbance in attention

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Sudden cardiac death0
Date modified: